Product logins

Find logins to all Clarivate products below.


Chronic Daily Headache – Epidemiology – Mature Markets

Clarivate Epidemiology’s coverage of chronic daily headache (CDH) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the prevalence of CDH for each country, as well as annualized case counts projected to the national population.

Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets.

Clarivate Epidemiology’s CDH forecast will answer the following question:

  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of CDH over the forecast period?

All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

In total, Clarivate Epidemiology forecasts four CDH patient populations, as follows:

  • Total prevalent cases of CDH.
  • Total prevalent cases of chronic tension-type headache (CTTH).
  • Total prevalent cases of chronic migraine (CM).
  • Total prevalent cases of chronic tension-type headache and chronic migraine (CTTH and CM).

Note: Coverage may vary by country.

Related Market Assessment Reports

Report
Diabetic Nephropathy – Current Treatment – Treatment Algorithms: Claims Data Analysis – Diabetic Nephropathy (US)
Diabetic nephropathy (DN), also referred to as diabetic kidney disease, is a common complication of diabetes. The DN drug market comprises a wide variety of antidiabetic and antihypertensive drugs…
Report
Endometrial Cancer – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of endometrial cancer comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of…
Report
Pemphigus Vulgaris – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of pemphigus vulgaris (PV) comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France…
Report
Pemphigus Vulgaris – Epidemiology – Extrapolated Worldwide Coverage
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key pemphigus vulgaris patient populations, covering 171 countries and…
Report
Pemphigus Vulgaris – Epidemiology – Epidemiology Dashboard
Clarivate Epidemiology’s coverage of pemphigus vulgaris comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the diagnosed prevalence and the…